Global Chemotheraphy-induced Nausea and Vomitting Treatment Market Growth (Status and Outlook) 2021-2026
According to this latest study, the 2021 growth of Chemotheraphy-induced Nausea and Vomitting Treatment will have significant change from previous year. By the most conservative estimates of global Chemotheraphy-induced Nausea and Vomitting Treatment market size (most likely outcome) will be a year-over-year revenue growth rate of XX% in 2021, from US$ xx million in 2020. Over the next five years the Chemotheraphy-induced Nausea and Vomitting Treatment market will register a xx% CAGR in terms of revenue, the global market size will reach US$ xx million by 2026.
This report presents a comprehensive overview, market shares, and growth opportunities of Chemotheraphy-induced Nausea and Vomitting Treatment market by product type, application, key players and key regions and countries.
Segmentation by type: breakdown data from 2016 to 2021 in Section 2.3; and forecast to 2026 in section 10.7.
Aloxi (Palonosetron)
Kytril (Granisetron)
Emend (Aprepitant)
Others
Segmentation by application: breakdown data from 2016 to 2021, in Section 2.4; and forecast to 2026 in section 10.8.
Acute Nausea and Vomitting Treatment
Delayed Nausea and Vomitting Treatment
Anticipatory Nausea and Vomitting Treatment
This report also splits the market by region: Breakdown data in Chapter 4, 5, 6, 7 and 8.
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries
The report also presents the market competition landscape and a corresponding detailed analysis of the major players in the market. The key players covered in this report: Breakdown data in in Chapter 3.
GlaxoSmithKline
Helsinn
Heron Therapeutics
Merck & Co
Tesaro
Acacia Pharma
Aphios
Barr Laboratories
Baxter Healthcare
Eisai
Especificos Stendhal
F.Hoffmann La Roche
Mundipharma
Mylan Pharmaceuticals
OPKO Health
Orchid Healthcare
Frequently Asked Questions
The base year for the study has been considered 2019, historic year 2014 and 2018, the forecast period considered is from 2020 to 2027. The regions analyzed for the market include North America, Europe, South America, Asia Pacific, and Middle East and Africa. These regions are further analyzed at the country-level. The study also includes attractiveness analysis of type, application and regions which are benchmarked based on their market size, growth rate and attractiveness in terms of present and future opportunity for understanding the future growth of the market.
Market is segmented on the basis:
- By Type
- By Application
- By Region
- By Country
- By Manufacturer
The report offers in-depth analysis of driving factors, opportunities, restraints, and challenges for gaining the key insight of the market. The report emphasizes on all the key trends that play a vital role in the enlargement of the market from 2019 to 2026.
The report provides company profile of the key players operating in the market and a comparative analysis based on their business overviews industry offering, segment market share, regional presence, business strategies, innovations, mergers & acquisitions, recent developments, joint venture, collaborations, partnerships, SWOT analysis, and key financial information.
1 Scope of the Report
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
2 Executive Summary
2.1 World Market Overview
2.1.1 Global Chemotheraphy-induced Nausea and Vomitting Treatment Market Size 2016-2026
2.1.2 Chemotheraphy-induced Nausea and Vomitting Treatment Market Size CAGR by Region 2020 VS 2021 VS 2026
2.2 Chemotheraphy-induced Nausea and Vomitting Treatment Segment by Type
2.2.1 Aloxi (Palonosetron)
2.2.2 Aloxi (Palonosetron)
2.2.3 Emend (Aprepitant)
2.2.4 Others
2.3 Chemotheraphy-induced Nausea and Vomitting Treatment Market Size by Type
2.3.1 Global Chemotheraphy-induced Nausea and Vomitting Treatment Market Size CAGR by Type
2.3.2 Global Chemotheraphy-induced Nausea and Vomitting Treatment Market Size Market Share by Type (2016-2021)
2.4 Chemotheraphy-induced Nausea and Vomitting Treatment Segment by Application
2.4.1 Acute Nausea and Vomitting Treatment
2.4.2 Delayed Nausea and Vomitting Treatment
2.4.3 Anticipatory Nausea and Vomitting Treatment
2.5 Chemotheraphy-induced Nausea and Vomitting Treatment Market Size by Application
2.5.1 Global Chemotheraphy-induced Nausea and Vomitting Treatment Market Size CAGR by Application
2.5.2 Global Chemotheraphy-induced Nausea and Vomitting Treatment Market Size Market Share by Application (2016-2021)
3 Chemotheraphy-induced Nausea and Vomitting Treatment Market Size by Players
3.1 Chemotheraphy-induced Nausea and Vomitting Treatment Market Size Market Share by Players
3.1.1 Global Chemotheraphy-induced Nausea and Vomitting Treatment Revenue by Players (2019-2021E)
3.1.2 Global Chemotheraphy-induced Nausea and Vomitting Treatment Revenue Market Share by Players (2019-2021E)
3.2 Global Chemotheraphy-induced Nausea and Vomitting Treatment Key Players Head office and Products Offered
3.3 Market Concentration Rate Analysis
3.3.1 Competition Landscape Analysis
3.3.2 Concentration Ratio (CR3, CR5 and CR10) (2019-2021E)
3.4 New Products and Potential Entrants
3.5 Mergers & Acquisitions, Expansion
4 Chemotheraphy-induced Nausea and Vomitting Treatment by Regions
4.1 Chemotheraphy-induced Nausea and Vomitting Treatment Market Size by Regions (2016-2021)
4.2 Americas Chemotheraphy-induced Nausea and Vomitting Treatment Market Size Growth (2016-2021)
4.3 APAC Chemotheraphy-induced Nausea and Vomitting Treatment Market Size Growth (2016-2021)
4.4 Europe Chemotheraphy-induced Nausea and Vomitting Treatment Market Size Growth (2016-2021)
4.5 Middle East & Africa Chemotheraphy-induced Nausea and Vomitting Treatment Market Size Growth (2016-2021)
5 Americas
5.1 Americas Chemotheraphy-induced Nausea and Vomitting Treatment Market Size by Country (2016-2021)
5.2 Americas Chemotheraphy-induced Nausea and Vomitting Treatment Market Size by Type (2016-2021)
5.3 Americas Chemotheraphy-induced Nausea and Vomitting Treatment Market Size by Application (2016-2021)
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Chemotheraphy-induced Nausea and Vomitting Treatment Market Size by Region (2016-2021)
6.2 APAC Chemotheraphy-induced Nausea and Vomitting Treatment Market Size by Type (2016-2021)
6.3 APAC Chemotheraphy-induced Nausea and Vomitting Treatment Market Size by Application (2016-2021)
6.4 China
6.5 Japan
6.6 Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
7 Europe
7.1 Europe Chemotheraphy-induced Nausea and Vomitting Treatment by Country (2016-2021)
7.2 Europe Chemotheraphy-induced Nausea and Vomitting Treatment Market Size by Type (2016-2021)
7.3 Europe Chemotheraphy-induced Nausea and Vomitting Treatment Market Size by Application (2016-2021)
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 Middle East & Africa
8.1 Middle East & Africa Chemotheraphy-induced Nausea and Vomitting Treatment by Region (2016-2021)
8.2 Middle East & Africa Chemotheraphy-induced Nausea and Vomitting Treatment Market Size by Type (2016-2021)
8.3 Middle East & Africa Chemotheraphy-induced Nausea and Vomitting Treatment Market Size by Application (2016-2021)
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 Market Drivers, Challenges and Trends
9.1 Market Drivers and Impact
9.1.1 Growing Demand from Key Regions
9.1.2 Growing Demand from Key Applications and Potential Industries
9.2 Market Challenges and Impact
9.3 Market Trends
10 Global Chemotheraphy-induced Nausea and Vomitting Treatment Market Forecast
10.1 Global Chemotheraphy-induced Nausea and Vomitting Treatment Forecast by Regions (2021-2026)
10.1.1 Global Chemotheraphy-induced Nausea and Vomitting Treatment Forecast by Regions (2021-2026)
10.1.2 Americas Chemotheraphy-induced Nausea and Vomitting Treatment Forecast
10.1.3 APAC Chemotheraphy-induced Nausea and Vomitting Treatment Forecast
10.1.4 Europe Chemotheraphy-induced Nausea and Vomitting Treatment Forecast
10.1.5 Middle East & Africa Chemotheraphy-induced Nausea and Vomitting Treatment Forecast
10.2 Americas Chemotheraphy-induced Nausea and Vomitting Treatment Forecast by Countries (2021-2026)
10.2.1 United States Chemotheraphy-induced Nausea and Vomitting Treatment Market Forecast
10.2.2 Canada Chemotheraphy-induced Nausea and Vomitting Treatment Market Forecast
10.2.3 Mexico Chemotheraphy-induced Nausea and Vomitting Treatment Market Forecast
10.2.4 Brazil Chemotheraphy-induced Nausea and Vomitting Treatment Market Forecast
10.3 APAC Chemotheraphy-induced Nausea and Vomitting Treatment Forecast by Region (2021-2026)
10.3.1 China Chemotheraphy-induced Nausea and Vomitting Treatment Market Forecast
10.3.2 Japan Chemotheraphy-induced Nausea and Vomitting Treatment Market Forecast
10.3.3 Korea Chemotheraphy-induced Nausea and Vomitting Treatment Market Forecast
10.3.4 Southeast Asia Chemotheraphy-induced Nausea and Vomitting Treatment Market Forecast
10.3.5 India Chemotheraphy-induced Nausea and Vomitting Treatment Market Forecast
10.3.6 Australia Chemotheraphy-induced Nausea and Vomitting Treatment Market Forecast
10.4 Europe Chemotheraphy-induced Nausea and Vomitting Treatment Forecast by Country (2021-2026)
10.4.1 Germany Chemotheraphy-induced Nausea and Vomitting Treatment Market Forecast
10.4.2 France Chemotheraphy-induced Nausea and Vomitting Treatment Market Forecast
10.4.3 UK Chemotheraphy-induced Nausea and Vomitting Treatment Market Forecast
10.4.4 Italy Chemotheraphy-induced Nausea and Vomitting Treatment Market Forecast
10.4.5 Russia Chemotheraphy-induced Nausea and Vomitting Treatment Market Forecast
10.5 Middle East & Africa Chemotheraphy-induced Nausea and Vomitting Treatment Forecast by Region (2021-2026)
10.5.1 Egypt Chemotheraphy-induced Nausea and Vomitting Treatment Market Forecast
10.5.2 South Africa Chemotheraphy-induced Nausea and Vomitting Treatment Market Forecast
10.5.3 Israel Chemotheraphy-induced Nausea and Vomitting Treatment Market Forecast
10.5.4 Turkey Chemotheraphy-induced Nausea and Vomitting Treatment Market Forecast
10.5.5 GCC Countries Chemotheraphy-induced Nausea and Vomitting Treatment Market Forecast
10.6 Global Chemotheraphy-induced Nausea and Vomitting Treatment Forecast by Type (2021-2026)
10.7 Global Chemotheraphy-induced Nausea and Vomitting Treatment Forecast by Application (2021-2026)
11 Key Players Analysis
11.1 GlaxoSmithKline
11.1.1 GlaxoSmithKline Company Information
11.1.2 GlaxoSmithKline Chemotheraphy-induced Nausea and Vomitting Treatment Product Offered
11.1.3 GlaxoSmithKline Chemotheraphy-induced Nausea and Vomitting Treatment Revenue, Gross Margin and Market Share (2019-2021)
11.1.4 GlaxoSmithKline Main Business Overview
11.1.5 GlaxoSmithKline Latest Developments
11.2 Helsinn
11.2.1 Helsinn Company Information
11.2.2 Helsinn Chemotheraphy-induced Nausea and Vomitting Treatment Product Offered
11.2.3 Helsinn Chemotheraphy-induced Nausea and Vomitting Treatment Revenue, Gross Margin and Market Share (2019-2021)
11.2.4 Helsinn Main Business Overview
11.2.5 Helsinn Latest Developments
11.3 Heron Therapeutics
11.3.1 Heron Therapeutics Company Information
11.3.2 Heron Therapeutics Chemotheraphy-induced Nausea and Vomitting Treatment Product Offered
11.3.3 Heron Therapeutics Chemotheraphy-induced Nausea and Vomitting Treatment Revenue, Gross Margin and Market Share (2019-2021)
11.3.4 Heron Therapeutics Main Business Overview
11.3.5 Heron Therapeutics Latest Developments
11.4 Merck & Co
11.4.1 Merck & Co Company Information
11.4.2 Merck & Co Chemotheraphy-induced Nausea and Vomitting Treatment Product Offered
11.4.3 Merck & Co Chemotheraphy-induced Nausea and Vomitting Treatment Revenue, Gross Margin and Market Share (2019-2021)
11.4.4 Merck & Co Main Business Overview
11.4.5 Merck & Co Latest Developments
11.5 Tesaro
11.5.1 Tesaro Company Information
11.5.2 Tesaro Chemotheraphy-induced Nausea and Vomitting Treatment Product Offered
11.5.3 Tesaro Chemotheraphy-induced Nausea and Vomitting Treatment Revenue, Gross Margin and Market Share (2019-2021)
11.5.4 Tesaro Main Business Overview
11.5.5 Tesaro Latest Developments
11.6 Acacia Pharma
11.6.1 Acacia Pharma Company Information
11.6.2 Acacia Pharma Chemotheraphy-induced Nausea and Vomitting Treatment Product Offered
11.6.3 Acacia Pharma Chemotheraphy-induced Nausea and Vomitting Treatment Revenue, Gross Margin and Market Share (2019-2021)
11.6.4 Acacia Pharma Main Business Overview
11.6.5 Acacia Pharma Latest Developments
11.7 Aphios
11.7.1 Aphios Company Information
11.7.2 Aphios Chemotheraphy-induced Nausea and Vomitting Treatment Product Offered
11.7.3 Aphios Chemotheraphy-induced Nausea and Vomitting Treatment Revenue, Gross Margin and Market Share (2019-2021)
11.7.4 Aphios Main Business Overview
11.7.5 Aphios Latest Developments
11.8 Barr Laboratories
11.8.1 Barr Laboratories Company Information
11.8.2 Barr Laboratories Chemotheraphy-induced Nausea and Vomitting Treatment Product Offered
11.8.3 Barr Laboratories Chemotheraphy-induced Nausea and Vomitting Treatment Revenue, Gross Margin and Market Share (2019-2021)
11.8.4 Barr Laboratories Main Business Overview
11.8.5 Barr Laboratories Latest Developments
11.9 Baxter Healthcare
11.9.1 Baxter Healthcare Company Information
11.9.2 Baxter Healthcare Chemotheraphy-induced Nausea and Vomitting Treatment Product Offered
11.9.3 Baxter Healthcare Chemotheraphy-induced Nausea and Vomitting Treatment Revenue, Gross Margin and Market Share (2019-2021)
11.9.4 Baxter Healthcare Main Business Overview
11.9.5 Baxter Healthcare Latest Developments
11.10 Eisai
11.10.1 Eisai Company Information
11.10.2 Eisai Chemotheraphy-induced Nausea and Vomitting Treatment Product Offered
11.10.3 Eisai Chemotheraphy-induced Nausea and Vomitting Treatment Revenue, Gross Margin and Market Share (2019-2021)
11.10.4 Eisai Main Business Overview
11.10.5 Eisai Latest Developments
11. Especificos Stendhal
11.11.1 Especificos Stendhal Company Information
11.11.2 Especificos Stendhal Chemotheraphy-induced Nausea and Vomitting Treatment Product Offered
11.11.3 Especificos Stendhal Chemotheraphy-induced Nausea and Vomitting Treatment Revenue, Gross Margin and Market Share (2019-2021)
11.11.4 Especificos Stendhal Main Business Overview
11.11.5 Especificos Stendhal Latest Developments
11.12 F.Hoffmann La Roche
11.12.1 F.Hoffmann La Roche Company Information
11.12.2 F.Hoffmann La Roche Chemotheraphy-induced Nausea and Vomitting Treatment Product Offered
11.12.3 F.Hoffmann La Roche Chemotheraphy-induced Nausea and Vomitting Treatment Revenue, Gross Margin and Market Share (2019-2021)
11.12.4 F.Hoffmann La Roche Main Business Overview
11.12.5 F.Hoffmann La Roche Latest Developments
11.13 Mundipharma
11.13.1 Mundipharma Company Information
11.13.2 Mundipharma Chemotheraphy-induced Nausea and Vomitting Treatment Product Offered
11.13.3 Mundipharma Chemotheraphy-induced Nausea and Vomitting Treatment Revenue, Gross Margin and Market Share (2019-2021)
11.13.4 Mundipharma Main Business Overview
11.13.5 Mundipharma Latest Developments
11.14 Mylan Pharmaceuticals
11.14.1 Mylan Pharmaceuticals Company Information
11.14.2 Mylan Pharmaceuticals Chemotheraphy-induced Nausea and Vomitting Treatment Product Offered
11.14.3 Mylan Pharmaceuticals Chemotheraphy-induced Nausea and Vomitting Treatment Revenue, Gross Margin and Market Share (2019-2021)
11.14.4 Mylan Pharmaceuticals Main Business Overview
11.14.5 Mylan Pharmaceuticals Latest Developments
11.15 OPKO Health
11.15.1 OPKO Health Company Information
11.15.2 OPKO Health Chemotheraphy-induced Nausea and Vomitting Treatment Product Offered
11.15.3 OPKO Health Chemotheraphy-induced Nausea and Vomitting Treatment Revenue, Gross Margin and Market Share (2019-2021)
11.15.4 OPKO Health Main Business Overview
11.15.5 OPKO Health Latest Developments
11.16 Orchid Healthcare
11.16.1 Orchid Healthcare Company Information
11.16.2 Orchid Healthcare Chemotheraphy-induced Nausea and Vomitting Treatment Product Offered
11.16.3 Orchid Healthcare Chemotheraphy-induced Nausea and Vomitting Treatment Revenue, Gross Margin and Market Share (2019-2021)
11.16.4 Orchid Healthcare Main Business Overview
11.16.5 Orchid Healthcare Latest Developments
12 Research Findings and Conclusion
List of Tables
Table 1. Chemotheraphy-induced Nausea and Vomitting Treatment Market Size CAGR by Region (2020-2026) & ($ Millions)
Table 2. Major Players of Aloxi (Palonosetron)
Table 3. Major Players of Kytril (Granisetron)
Table 4. Major Players of Emend (Aprepitant)
Table 5. Major Players of Others
Table 6. Chemotheraphy-induced Nausea and Vomitting Treatment Market Size CAGR by Type (2020-2026) & ($ Millions)
Table 7. Global Chemotheraphy-induced Nausea and Vomitting Treatment Market Size by Type (2016-2021) & ($ Millions)
Table 8. Global Chemotheraphy-induced Nausea and Vomitting Treatment Market Size Market Share by Type (2016-2021)
Table 9. Chemotheraphy-induced Nausea and Vomitting Treatment Market Size CAGR by Application (2016-2021) & ($ Millions)
Table 10. Global Chemotheraphy-induced Nausea and Vomitting Treatment Market Size by Application (2016-2021) & ($ Millions)
Table 11. Global Chemotheraphy-induced Nausea and Vomitting Treatment Market Size Market Share by Application (2016-2021)
Table 12. Global Chemotheraphy-induced Nausea and Vomitting Treatment Revenue by Players (2019-2021E) & ($ Millions)
Table 13. Global Chemotheraphy-induced Nausea and Vomitting Treatment Revenue Market Share by Players (2019-2021E)
Table 14. Chemotheraphy-induced Nausea and Vomitting Treatment Key Players Head office and Products Offered
Table 15. Chemotheraphy-induced Nausea and Vomitting Treatment Concentration Ratio (CR3, CR5 and CR10) & (2019-2021E)
Table 16. New Products and Potential Entrants
Table 17. Mergers & Acquisitions, Expansion
Table 18. Global Chemotheraphy-induced Nausea and Vomitting Treatment Market Size by Regions 2016-2021 & ($ Millions)
Table 19. Global Chemotheraphy-induced Nausea and Vomitting Treatment Market Size Market Share by Regions 2016-2021
Table 20. Americas Chemotheraphy-induced Nausea and Vomitting Treatment Market Size by Country (2016-2021) & ($ Millions)
Table 21. Americas Chemotheraphy-induced Nausea and Vomitting Treatment Market Size Market Share by Country (2016-2021)
Table 22. Americas Chemotheraphy-induced Nausea and Vomitting Treatment Market Size by Type (2016-2021) & ($ Millions)
Table 23. Americas Chemotheraphy-induced Nausea and Vomitting Treatment Market Size Market Share by Type (2016-2021)
Table 24. Americas Chemotheraphy-induced Nausea and Vomitting Treatment Market Size by Application (2016-2021) & ($ Millions)
Table 25. Americas Chemotheraphy-induced Nausea and Vomitting Treatment Market Size Market Share by Application (2016-2021)
Table 26. APAC Chemotheraphy-induced Nausea and Vomitting Treatment Market Size by Region (2016-2021) & ($ Millions)
Table 27. APAC Chemotheraphy-induced Nausea and Vomitting Treatment Market Size Market Share by Region (2016-2021)
Table 28. APAC Chemotheraphy-induced Nausea and Vomitting Treatment Market Size by Type (2016-2021) & ($ Millions)
Table 29. APAC Chemotheraphy-induced Nausea and Vomitting Treatment Market Size Market Share by Type (2016-2021)
Table 30. APAC Chemotheraphy-induced Nausea and Vomitting Treatment Market Size by Application (2016-2021) & ($ Millions)
Table 31. APAC Chemotheraphy-induced Nausea and Vomitting Treatment Market Size Market Share by Application (2016-2021)
Table 32. Europe Chemotheraphy-induced Nausea and Vomitting Treatment Market Size by Country (2016-2021) & ($ Millions)
Table 33. Europe Chemotheraphy-induced Nausea and Vomitting Treatment Market Size Market Share by Country (2016-2021)
Table 34. Europe Chemotheraphy-induced Nausea and Vomitting Treatment Market Size by Type (2016-2021) & ($ Millions)
Table 35. Europe Chemotheraphy-induced Nausea and Vomitting Treatment Market Size Market Share by Type (2016-2021)
Table 36. Europe Chemotheraphy-induced Nausea and Vomitting Treatment Market Size by Application (2016-2021) & ($ Millions)
Table 37. Europe Chemotheraphy-induced Nausea and Vomitting Treatment Market Size Market Share by Application (2016-2021)
Table 38. Middle East & Africa Chemotheraphy-induced Nausea and Vomitting Treatment Market Size by Region (2016-2021) & ($ Millions)
Table 39. Middle East & Africa Chemotheraphy-induced Nausea and Vomitting Treatment Market Size Market Share by Region (2016-2021)
Table 40. Middle East & Africa Chemotheraphy-induced Nausea and Vomitting Treatment Market Size by Type (2016-2021) & ($ Millions)
Table 41. Middle East & Africa Chemotheraphy-induced Nausea and Vomitting Treatment Market Size Market Share by Type (2016-2021)
Table 42. Middle East & Africa Chemotheraphy-induced Nausea and Vomitting Treatment Market Size by Application (2016-2021) & ($ Millions)
Table 43. Middle East & Africa Chemotheraphy-induced Nausea and Vomitting Treatment Market Size Market Share by Application (2016-2021)
Table 44. Key and Potential Regions of Chemotheraphy-induced Nausea and Vomitting Treatment
Table 45. Key Application and Potential Industries of Chemotheraphy-induced Nausea and Vomitting Treatment
Table 46. Key Challenges of Chemotheraphy-induced Nausea and Vomitting Treatment
Table 47. Key Trends of Chemotheraphy-induced Nausea and Vomitting Treatment
Table 48. Global Chemotheraphy-induced Nausea and Vomitting Treatment Market Size Forecast by Regions (2021-2026) & ($ Millions)
Table 49. Global Chemotheraphy-induced Nausea and Vomitting Treatment Market Size Market Share Forecast by Regions (2021-2026)
Table 50. Global Chemotheraphy-induced Nausea and Vomitting Treatment Market Size Forecast by Type (2021-2026) & ($ Millions)
Table 51. Global Chemotheraphy-induced Nausea and Vomitting Treatment Market Size Market Share Forecast by Type (2021-2026)
Table 52. Global Chemotheraphy-induced Nausea and Vomitting Treatment Market Size Forecast by Application (2021-2026) & ($ Millions)
Table 53. Global Chemotheraphy-induced Nausea and Vomitting Treatment Market Size Market Share Forecast by Application (2021-2026)
Table 54. GlaxoSmithKline Details, Company Type, Chemotheraphy-induced Nausea and Vomitting Treatment Area Served and Its Competitors
Table 55. GlaxoSmithKline Chemotheraphy-induced Nausea and Vomitting Treatment Product Offered
Table 56. GlaxoSmithKline Chemotheraphy-induced Nausea and Vomitting Treatment Revenue ($ million), Gross Margin and Market Share (2019-2021E)
Table 57. GlaxoSmithKline Main Business
Table 58. GlaxoSmithKline Latest Developments
Table 59. Helsinn Details, Company Type, Chemotheraphy-induced Nausea and Vomitting Treatment Area Served and Its Competitors
Table 60. Helsinn Chemotheraphy-induced Nausea and Vomitting Treatment Product Offered
Table 61. Helsinn Main Business
Table 62. Helsinn Chemotheraphy-induced Nausea and Vomitting Treatment Revenue ($ million), Gross Margin and Market Share (2019-2021E)
Table 63. Helsinn Latest Developments
Table 64. Heron Therapeutics Details, Company Type, Chemotheraphy-induced Nausea and Vomitting Treatment Area Served and Its Competitors
Table 65. Heron Therapeutics Chemotheraphy-induced Nausea and Vomitting Treatment Product Offered
Table 66. Heron Therapeutics Main Business
Table 67. Heron Therapeutics Chemotheraphy-induced Nausea and Vomitting Treatment Revenue ($ million), Gross Margin and Market Share (2019-2021E)
Table 68. Heron Therapeutics Latest Developments
Table 69. Merck & Co Details, Company Type, Chemotheraphy-induced Nausea and Vomitting Treatment Area Served and Its Competitors
Table 70. Merck & Co Chemotheraphy-induced Nausea and Vomitting Treatment Product Offered
Table 71. Merck & Co Main Business
Table 72. Merck & Co Chemotheraphy-induced Nausea and Vomitting Treatment Revenue ($ million), Gross Margin and Market Share (2019-2021E)
Table 73. Merck & Co Latest Developments
Table 74. Tesaro Details, Company Type, Chemotheraphy-induced Nausea and Vomitting Treatment Area Served and Its Competitors
Table 75. Tesaro Chemotheraphy-induced Nausea and Vomitting Treatment Product Offered
Table 76. Tesaro Main Business
Table 77. Tesaro Chemotheraphy-induced Nausea and Vomitting Treatment Revenue ($ million), Gross Margin and Market Share (2019-2021E)
Table 78. Tesaro Latest Developments
Table 79. Acacia Pharma Details, Company Type, Chemotheraphy-induced Nausea and Vomitting Treatment Area Served and Its Competitors
Table 80. Acacia Pharma Chemotheraphy-induced Nausea and Vomitting Treatment Product Offered
Table 81. Acacia Pharma Main Business
Table 82. Acacia Pharma Chemotheraphy-induced Nausea and Vomitting Treatment Revenue ($ million), Gross Margin and Market Share (2019-2021E)
Table 83. Acacia Pharma Latest Developments
Table 84. Aphios Details, Company Type, Chemotheraphy-induced Nausea and Vomitting Treatment Area Served and Its Competitors
Table 85. Aphios Chemotheraphy-induced Nausea and Vomitting Treatment Product Offered
Table 86. Aphios Main Business
Table 87. Aphios Chemotheraphy-induced Nausea and Vomitting Treatment Revenue ($ million), Gross Margin and Market Share (2019-2021E)
Table 88. Aphios Latest Developments
Table 89. Barr Laboratories Details, Company Type, Chemotheraphy-induced Nausea and Vomitting Treatment Area Served and Its Competitors
Table 90. Barr Laboratories Chemotheraphy-induced Nausea and Vomitting Treatment Product Offered
Table 91. Barr Laboratories Main Business
Table 92. Barr Laboratories Chemotheraphy-induced Nausea and Vomitting Treatment Revenue ($ million), Gross Margin and Market Share (2019-2021E)
Table 93. Barr Laboratories Latest Developments
Table 94. Baxter Healthcare Details, Company Type, Chemotheraphy-induced Nausea and Vomitting Treatment Area Served and Its Competitors
Table 95. Baxter Healthcare Chemotheraphy-induced Nausea and Vomitting Treatment Product Offered
Table 96. Baxter Healthcare Main Business
Table 97. Baxter Healthcare Chemotheraphy-induced Nausea and Vomitting Treatment Revenue ($ million), Gross Margin and Market Share (2019-2021E)
Table 98. Baxter Healthcare Latest Developments
Table 99. Eisai Details, Company Type, Chemotheraphy-induced Nausea and Vomitting Treatment Area Served and Its Competitors
Table 100. Eisai Chemotheraphy-induced Nausea and Vomitting Treatment Product Offered
Table 101. Eisai Main Business
Table 102. Eisai Chemotheraphy-induced Nausea and Vomitting Treatment Revenue ($ million), Gross Margin and Market Share (2019-2021E)
Table 103. Eisai Latest Developments
Table 104. Especificos Stendhal Details, Company Type, Chemotheraphy-induced Nausea and Vomitting Treatment Area Served and Its Competitors
Table 105. Especificos Stendhal Chemotheraphy-induced Nausea and Vomitting Treatment Product Offered
Table 106. Especificos Stendhal Chemotheraphy-induced Nausea and Vomitting Treatment Revenue ($ million), Gross Margin and Market Share (2019-2021E)
Table 107. Especificos Stendhal Main Business
Table 108. Especificos Stendhal Latest Developments
Table 109. F.Hoffmann La Roche Details, Company Type, Chemotheraphy-induced Nausea and Vomitting Treatment Area Served and Its Competitors
Table 110. F.Hoffmann La Roche Chemotheraphy-induced Nausea and Vomitting Treatment Product Offered
Table 111. F.Hoffmann La Roche Main Business
Table 112. F.Hoffmann La Roche Chemotheraphy-induced Nausea and Vomitting Treatment Revenue ($ million), Gross Margin and Market Share (2019-2021E)
Table 113. F.Hoffmann La Roche Latest Developments
Table 114. Mundipharma Details, Company Type, Chemotheraphy-induced Nausea and Vomitting Treatment Area Served and Its Competitors
Table 115. Mundipharma Chemotheraphy-induced Nausea and Vomitting Treatment Product Offered
Table 116. Mundipharma Main Business
Table 117. Mundipharma Chemotheraphy-induced Nausea and Vomitting Treatment Revenue ($ million), Gross Margin and Market Share (2019-2021E)
Table 118. Mundipharma Latest Developments
Table 119. Mylan Pharmaceuticals Details, Company Type, Chemotheraphy-induced Nausea and Vomitting Treatment Area Served and Its Competitors
Table 120. Mylan Pharmaceuticals Chemotheraphy-induced Nausea and Vomitting Treatment Product Offered
Table 121. Mylan Pharmaceuticals Main Business
Table 122. Mylan Pharmaceuticals Chemotheraphy-induced Nausea and Vomitting Treatment Revenue ($ million), Gross Margin and Market Share (2019-2021E)
Table 123. Mylan Pharmaceuticals Latest Developments
Table 124. OPKO Health Details, Company Type, Chemotheraphy-induced Nausea and Vomitting Treatment Area Served and Its Competitors
Table 125. OPKO Health Chemotheraphy-induced Nausea and Vomitting Treatment Product Offered
Table 126. OPKO Health Main Business
Table 127. OPKO Health Chemotheraphy-induced Nausea and Vomitting Treatment Revenue ($ million), Gross Margin and Market Share (2019-2021E)
Table 128. OPKO Health Latest Developments
Table 129. Orchid Healthcare Details, Company Type, Chemotheraphy-induced Nausea and Vomitting Treatment Area Served and Its Competitors
Table 130. Orchid Healthcare Chemotheraphy-induced Nausea and Vomitting Treatment Product Offered
Table 131. Orchid Healthcare Main Business
Table 132. Orchid Healthcare Chemotheraphy-induced Nausea and Vomitting Treatment Revenue ($ million), Gross Margin and Market Share (2019-2021E)
Table 133. Orchid Healthcare Latest Developments
List of Figures
Figure 1. Chemotheraphy-induced Nausea and Vomitting Treatment Report Years Considered
Figure 2. Research Objectives
Figure 3. Research Methodology
Figure 4. Research Process and Data Source
Figure 5. Global Chemotheraphy-induced Nausea and Vomitting Treatment Market Size Growth Rate 2016-2026 ($ Millions)
Figure 6. Global Chemotheraphy-induced Nausea and Vomitting Treatment Market Size Market Share by Type in 2020
Figure 7. Chemotheraphy-induced Nausea and Vomitting Treatment in Acute Nausea and Vomitting Treatment
Figure 8. Global Chemotheraphy-induced Nausea and Vomitting Treatment Market: Acute Nausea and Vomitting Treatment (2016-2021) & ($ Millions)
Figure 9. Chemotheraphy-induced Nausea and Vomitting Treatment in Delayed Nausea and Vomitting Treatment
Figure 10. Global Chemotheraphy-induced Nausea and Vomitting Treatment Market: Delayed Nausea and Vomitting Treatment (2016-2021) & ($ Millions)
Figure 11. Chemotheraphy-induced Nausea and Vomitting Treatment in Anticipatory Nausea and Vomitting Treatment
Figure 12. Global Chemotheraphy-induced Nausea and Vomitting Treatment Market: Anticipatory Nausea and Vomitting Treatment (2016-2021) & ($ Millions)
Figure 13. Global Chemotheraphy-induced Nausea and Vomitting Treatment Market Size Market Share by Application in 2020
Figure 14. Global Chemotheraphy-induced Nausea and Vomitting Treatment Revenue Market Share by Player in 2020
Figure 15. Global Chemotheraphy-induced Nausea and Vomitting Treatment Market Size Market Share by Regions (2016-2021)
Figure 16. Americas Chemotheraphy-induced Nausea and Vomitting Treatment Market Size 2016-2021 ($ Millions)
Figure 17. APAC Chemotheraphy-induced Nausea and Vomitting Treatment Market Size 2016-2021 ($ Millions)
Figure 18. Europe Chemotheraphy-induced Nausea and Vomitting Treatment Market Size 2016-2021 ($ Millions)
Figure 19. Middle East & Africa Chemotheraphy-induced Nausea and Vomitting Treatment Market Size 2016-2021 ($ Millions)
Figure 20. Americas Chemotheraphy-induced Nausea and Vomitting Treatment Market Size Market Share by Country in 2020
Figure 21. Americas Chemotheraphy-induced Nausea and Vomitting Treatment Market Size Market Share by Type in 2020
Figure 22. Americas Chemotheraphy-induced Nausea and Vomitting Treatment Market Size Market Share by Application in 2020
Figure 23. United States Chemotheraphy-induced Nausea and Vomitting Treatment Market Size Growth 2016-2021 ($ Millions)
Figure 24. Canada Chemotheraphy-induced Nausea and Vomitting Treatment Market Size Growth 2016-2021 ($ Millions)
Figure 25. Mexico Chemotheraphy-induced Nausea and Vomitting Treatment Market Size Growth 2016-2021 ($ Millions)
Figure 26. APAC Chemotheraphy-induced Nausea and Vomitting Treatment Market Size Market Share by Regions in 2020
Figure 27. APAC Chemotheraphy-induced Nausea and Vomitting Treatment Market Size Market Share by Type in 2020
Figure 28. APAC Chemotheraphy-induced Nausea and Vomitting Treatment Market Size Market Share by Application in 2020
Figure 29. China Chemotheraphy-induced Nausea and Vomitting Treatment Market Size Growth 2016-2021 ($ Millions)
Figure 30. Japan Chemotheraphy-induced Nausea and Vomitting Treatment Market Size Growth 2016-2021 ($ Millions)
Figure 31. Korea Chemotheraphy-induced Nausea and Vomitting Treatment Market Size Growth 2016-2021 ($ Millions)
Figure 32. Southeast Asia Chemotheraphy-induced Nausea and Vomitting Treatment Market Size Growth 2016-2021 ($ Millions)
Figure 33. India Chemotheraphy-induced Nausea and Vomitting Treatment Market Size Growth 2016-2021 ($ Millions)
Figure 34. Australia Chemotheraphy-induced Nausea and Vomitting Treatment Market Size Growth 2016-2021 ($ Millions)
Figure 35. Europe Chemotheraphy-induced Nausea and Vomitting Treatment Market Size Market Share by Country in 2020
Figure 36. Europe Chemotheraphy-induced Nausea and Vomitting Treatment Market Size Market Share by Type in 2020
Figure 37. Europe Chemotheraphy-induced Nausea and Vomitting Treatment Market Size Market Share by Application in 2020
Figure 38. Germany Chemotheraphy-induced Nausea and Vomitting Treatment Market Size Growth 2016-2021 ($ Millions)
Figure 39. France Chemotheraphy-induced Nausea and Vomitting Treatment Market Size Growth 2016-2021 ($ Millions)
Figure 40. UK Chemotheraphy-induced Nausea and Vomitting Treatment Market Size Growth 2016-2021 ($ Millions)
Figure 41. Italy Chemotheraphy-induced Nausea and Vomitting Treatment Market Size Growth 2016-2021 ($ Millions)
Figure 42. Russia Chemotheraphy-induced Nausea and Vomitting Treatment Market Size Growth 2016-2021 ($ Millions)
Figure 43. Middle East & Africa Chemotheraphy-induced Nausea and Vomitting Treatment Market Size Market Share by Region in 2020
Figure 44. Middle East & Africa Chemotheraphy-induced Nausea and Vomitting Treatment Market Size Market Share by Type in 2020
Figure 45. Middle East & Africa Chemotheraphy-induced Nausea and Vomitting Treatment Market Size Market Share by Application in 2020
Figure 46. Egypt Chemotheraphy-induced Nausea and Vomitting Treatment Market Size Growth 2016-2021 ($ Millions)
Figure 47. South Africa Chemotheraphy-induced Nausea and Vomitting Treatment Market Size Growth 2016-2021 ($ Millions)
Figure 48. Israel Chemotheraphy-induced Nausea and Vomitting Treatment Market Size Growth 2016-2021 ($ Millions)
Figure 49. Turkey Chemotheraphy-induced Nausea and Vomitting Treatment Market Size Growth 2016-2021 ($ Millions)
Figure 50. GCC Country Chemotheraphy-induced Nausea and Vomitting Treatment Market Size Growth 2016-2021 ($ Millions)
Figure 51. Americas Chemotheraphy-induced Nausea and Vomitting Treatment Market Size 2021-2026 ($ Millions)
Figure 52. APAC Chemotheraphy-induced Nausea and Vomitting Treatment Market Size 2021-2026 ($ Millions)
Figure 53. Europe Chemotheraphy-induced Nausea and Vomitting Treatment Market Size 2021-2026 ($ Millions)
Figure 54. Middle East & Africa Chemotheraphy-induced Nausea and Vomitting Treatment Market Size 2021-2026 ($ Millions)
Figure 55. United States Chemotheraphy-induced Nausea and Vomitting Treatment Market Size 2021-2026 ($ Millions)
Figure 56. Canada Chemotheraphy-induced Nausea and Vomitting Treatment Market Size 2021-2026 ($ Millions)
Figure 57. Mexico Chemotheraphy-induced Nausea and Vomitting Treatment Market Size 2021-2026 ($ Millions)
Figure 58. Brazil Chemotheraphy-induced Nausea and Vomitting Treatment Market Size 2021-2026 ($ Millions)
Figure 59. China Chemotheraphy-induced Nausea and Vomitting Treatment Market Size 2021-2026 ($ Millions)
Figure 60. Japan Chemotheraphy-induced Nausea and Vomitting Treatment Market Size 2021-2026 ($ Millions)
Figure 61. Korea Chemotheraphy-induced Nausea and Vomitting Treatment Market Size 2021-2026 ($ Millions)
Figure 62. Southeast Asia Chemotheraphy-induced Nausea and Vomitting Treatment Market Size 2021-2026 ($ Millions)
Figure 63. India Chemotheraphy-induced Nausea and Vomitting Treatment Market Size 2021-2026 ($ Millions)
Figure 64. Australia Chemotheraphy-induced Nausea and Vomitting Treatment Market Size 2021-2026 ($ Millions)
Figure 65. Germany Chemotheraphy-induced Nausea and Vomitting Treatment Market Size 2021-2026 ($ Millions)
Figure 66. France Chemotheraphy-induced Nausea and Vomitting Treatment Market Size 2021-2026 ($ Millions)
Figure 67. UK Chemotheraphy-induced Nausea and Vomitting Treatment Market Size 2021-2026 ($ Millions)
Figure 68. Italy Chemotheraphy-induced Nausea and Vomitting Treatment Market Size 2021-2026 ($ Millions)
Figure 69. Russia Chemotheraphy-induced Nausea and Vomitting Treatment Market Size 2021-2026 ($ Millions)
Figure 70. Spain Chemotheraphy-induced Nausea and Vomitting Treatment Market Size 2021-2026 ($ Millions)
Figure 71. Egypt Chemotheraphy-induced Nausea and Vomitting Treatment Market Size 2021-2026 ($ Millions)
Figure 72. South Africa Chemotheraphy-induced Nausea and Vomitting Treatment Market Size 2021-2026 ($ Millions)
Figure 73. Israel Chemotheraphy-induced Nausea and Vomitting Treatment Market Size 2021-2026 ($ Millions)
Figure 74. Turkey Chemotheraphy-induced Nausea and Vomitting Treatment Market Size 2021-2026 ($ Millions)
Figure 75. GCC Country Chemotheraphy-induced Nausea and Vomitting Treatment Market Size 2021-2026 ($ Millions)
